Biotech
Trump administration works to strengthen defenses against potential AI bioattacks - report
The Trump administration is reviving biosecurity efforts years after slashing related government departments amid growing fears that AI could enable biological attacks.
Israeli plant-based protein co Plantopia raises $9m
Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada
Israeli health-tech conference opens in Jerusalem with 1,800 participants from 40 countries
TAU Prof. Dan Peer appointed as member of American National Academy of Engineering
The National Academy of Engineering (NAE),has announced the appointment of Prof. Dan Peer from TAU as a Member of the Academy, in recognition of his groundbreaking research.
Biomica raises $20m. to advance pipeline of microbiome-based therapeutics
The financing round will be led by Shanghai Healthcare Capital, meaning it's subject to the clearance of Chinese regulatory authorities.
Israel develops cutting edge medication technology
The research was led by doctoral student Itai Katzir and supervised by Dr. Ayala Lampel from TAU’s Shmunis School of Biomedicine and Cancer Research at the Wise Faculty of Life Sciences.
New at-home brain monitoring solution launched by X-trodes, Emotiv
The collaboration pairs X-trodes’ wearable sensing technology with EmotivPRO, EMOTIV’s EEG data platform for neuroscience research.
Israeli breakthrough company seeks to use cells to improve quality of life
The biotechnology company Pluri, is expanding its activities and establishing strategic collaborations for the development and marketing of food-tech and pharmaceutical products.
EU regulator backs two Omicron-adapted COVID boosters
Developed by Moderna and the team of Pfizer and BioNTech, the new so-called bivalent shots combat the BA.1 version of Omicron and the original virus first detected in China.
How do you make it to the top? Three female leaders give their best advice
What are three mottos you should swear by, according to three of the biggest biotechnological leaders in Israel?
CRISPR gene editing may cause permanent damage - study
Caution from researchers at Tel Aviv University: CRISPR gene editing can damage the genome and might trigger cancer.
Precise Bio partners with ZEISS to develop bio-printed cornea implants
These bio-printed eye tissues would be used for transplants to treat vision correction and corneal diseases such as keratoconus.
BioGenCell raises $16m. for chronic disease treatment
The company’s treatment has already prevented loss of limb in several patients during Phase I trials.
